# Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers

> **NCT04704232** · PHASE1 · COMPLETED · sponsor: **AlzeCure Pharma** · enrollment: 24 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** ACD440
- **DRUG:** PLAC

## Key facts

- **NCT ID:** NCT04704232
- **Lead sponsor:** AlzeCure Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-12
- **Primary completion:** 2021-03-10
- **Final completion:** 2021-03-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04704232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04704232, "Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04704232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*